Artemis Medicare

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE025R01021
  • NSEID: ARTEMISMED
  • BSEID: 542919
INR
269.00
1.65 (0.62%)
BSENSE

Dec 05

BSE+NSE Vol: 1.4 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
529.66
464.63
434.55
354.69
261.32
155.06
283.05
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
529.66
464.63
434.55
354.69
261.32
155.06
283.05
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
41.91
69.58
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.08
0.23
0.78
(Increase) / Decrease In Stocks
0.00
0.01
0.00
0.00
0.06
2.21
-0.62
Employee Cost
77.68
71.76
68.19
58.43
49.11
40.23
50.52
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
322.73
278.85
272.08
224.30
160.58
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
37.24
35.58
32.17
29.26
18.80
71.58
130.93
Total Expenditure (Excl Depreciation)
437.65
386.20
372.44
311.99
228.63
156.15
251.19
Operating Profit (PBDIT) excl Other Income
92.01
78.43
62.11
42.70
32.69
-1.09
31.86
Other Income
14.58
11.84
3.67
3.72
1.66
1.46
1.83
Operating Profit (PBDIT)
106.59
90.27
65.78
46.42
34.35
0.37
33.69
Interest
14.57
16.11
14.76
9.22
5.08
7.26
6.77
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
92.02
74.16
51.02
37.20
29.27
-6.89
26.92
Depreciation
22.87
21.97
19.12
13.91
10.22
11.06
11.13
Profit Before Tax
69.16
52.19
31.91
23.29
19.05
-17.96
15.78
Tax
17.96
13.54
8.62
6.25
7.22
-6.22
6.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
51.20
38.66
23.29
17.04
11.83
-11.74
9.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
51.20
38.66
23.29
17.04
11.83
-11.74
9.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.05
0.27
0.12
0.51
0.24
0.19
0.21
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.25
38.93
23.41
17.55
12.07
-11.55
9.86
Equity Capital
13.89
13.76
13.59
13.34
13.24
13.24
13.24
Face Value
1.0
1.0
1.0
1.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.69
2.83
1.72
1.32
9.12
-8.72
7.45
Diluted Earnings per share
3.24
2.54
0.68
1.26
0.87
-8.73
7.45
Operating Profit Margin (Excl OI)
17.37%
16.88%
14.29%
12.04%
12.51%
-0.7%
11.26%
Gross Profit Margin
17.37%
15.96%
11.74%
10.49%
11.2%
-4.44%
9.51%
PAT Margin
9.67%
8.32%
5.36%
4.8%
4.53%
-7.57%
3.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 14.00% vs 6.92% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 31.65% vs 66.30% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 17.31% vs 26.28% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is -9.56% vs 9.15% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Artemis Medicare With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
529.66
0
529.66
Other Operating Income
0.00
0.00
0.00
Total Operating income
529.66
0
529.66
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.00
0
0.00
Employee Cost
77.68
0
77.68
Power Cost
0.00
0
0.00
Manufacturing Expenses
322.73
0
322.73
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
37.24
0.00
37.24
Total Expenditure (Excl Depreciation)
437.65
0
437.65
Operating Profit (PBDIT) excl Other Income
92.01
0.00
92.01
Other Income
14.58
0
14.58
Operating Profit (PBDIT)
106.59
0
106.59
Interest
14.57
0
14.57
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
92.02
0
92.02
Depreciation
22.87
0
22.87
Profit Before Tax
69.16
0
69.16
Tax
17.96
0
17.96
Provisions and contingencies
0.00
0
0.00
Profit After Tax
51.20
0
51.20
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
51.20
0
51.20
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.05
0
0.05
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.25
0
51.25
Equity Capital
13.89
0
13.89
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
3.69
0
3.69
Diluted Earnings per share
3.24
0
3.24
Operating Profit Margin (Excl OI)
17.37%
0%
0.00
17.37%
Gross Profit Margin
17.37%
0%
0.00
17.37%
PAT Margin
9.67%
0%
0.00
9.67%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 529.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 14.00% vs 6.92% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 51.25 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 31.65% vs 66.30% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 92.01 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 17.31% vs 26.28% in Sep 2024

Half Yearly - Interest
Interest 14.57 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -9.56% vs 9.15% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.37%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024